Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Geddes

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Evidence-Based Mental Health|November 23, 2021
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depressionSheena Kristine Au-Yeung, James Griffiths, Sophie Roberts, et al.
Contemporary Clinical Trials Communications|April 16, 2025
Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeuticsLaurence S J Roope, Jessica Walsh, Maddie Welland, et al.
Studies in Health Technology and Informatics|July 11, 2006
Designing for e-Health: recurring scenarios in developing grid-based medical imaging systemsJohn Geddes, Clare Mackay, Sharon Lloyd, et al.
Brain : a Journal of Neurology|June 9, 2022
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitisAdam Al-Diwani, Jakob Theorell, Valentina Damato, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 14, 2008
Wake-up call for British psychiatryNick Craddock, Danny Antebi, Mary-Jane Attenburrow, et al.
Health Technology Assessment (Winchester, England)|June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trialHamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Journal of Psychopharmacology (Oxford, England)|January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Thorax|March 31, 2022
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19Linzy Houchen-Wolloff, Krisnah Poinasamy, Kate Holmes, et al.
International Journal of Bipolar Disorders|April 2, 2017
Erratum to: Online information seeking by patients with bipolar disorder: results from an international multisite surveyJörn Conell, Rita Bauer, Tasha Glenn, et al.
Psychiatry Research|July 9, 2016
Internet use by patients with bipolar disorder: Results from an international multisite surveyRita Bauer, Jörn Conell, Tasha Glenn, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Evidence-Based Mental Health|November 23, 2021
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depressionSheena Kristine Au-Yeung, James Griffiths, Sophie Roberts, et al.
Contemporary Clinical Trials Communications|April 16, 2025
Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeuticsLaurence S J Roope, Jessica Walsh, Maddie Welland, et al.
Studies in Health Technology and Informatics|July 11, 2006
Designing for e-Health: recurring scenarios in developing grid-based medical imaging systemsJohn Geddes, Clare Mackay, Sharon Lloyd, et al.
Brain : a Journal of Neurology|June 9, 2022
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitisAdam Al-Diwani, Jakob Theorell, Valentina Damato, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 14, 2008
Wake-up call for British psychiatryNick Craddock, Danny Antebi, Mary-Jane Attenburrow, et al.
Health Technology Assessment (Winchester, England)|June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trialHamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Journal of Psychopharmacology (Oxford, England)|January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Thorax|March 31, 2022
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19Linzy Houchen-Wolloff, Krisnah Poinasamy, Kate Holmes, et al.
International Journal of Bipolar Disorders|April 2, 2017
Erratum to: Online information seeking by patients with bipolar disorder: results from an international multisite surveyJörn Conell, Rita Bauer, Tasha Glenn, et al.
Psychiatry Research|July 9, 2016
Internet use by patients with bipolar disorder: Results from an international multisite surveyRita Bauer, Jörn Conell, Tasha Glenn, et al.
Pageof 12